Resmed CDI (ASX:RMD)
share price: (EoD)
earnings per share:
dividends per share:
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Resmed CDI (ASX:RMD) share price
Resmed CDI (ASX:RMD) passive income
Resmed CDI (ASX:RMD) share price news
2 ASX shares I can’t ignore: RMD and WOW
The Resmed CDI (ASX:RMD) share price is lower 6.0% since the start of the 2024. It’s probably worth asking, ‘is the RMD share price priced to perfection?’
24 ASX Share Ideas For 2024
In this ASX investing guide, we will be introducing 24 ASX share ideas worth keeping an eye on in 2024.
The Woolworths Group Ltd (ASX:WOW) share price and Resmed CDI (ASX:RMD) share price are worth watching
The Woolworths Group Ltd (ASX:WOW) share price has risen 8.8% since the start of the 2024. It’s probably worth asking, ‘is the WOW share price top value?’
RMD and Csl LTD: 2 ASX shares to dig into
The Resmed CDI (ASX:RMD) share price has decreased 3.2% since the start of the 2024. It’s probably worth asking, ‘is the RMD share price good value?’
WOW and Resmed CDI: 2 ASX shares to dig into
The Woolworths Group Ltd (ASX:WOW) share price is up 9.9% since the start of the 2024. It’s probably worth asking, ‘is the WOW share price good value?’
ResMed Inc (ASX:RMD) & Magellan (ASX:MFG)
A deep dive into ResMed Inc (ASX: RMD) shares and Magellan Financial Group Ltd (ASX: MFG) shares by Rask’s Chief Investment Officer, Owen Rask.
The Resmed CDI (ASX:RMD) share price and Csl LTD (ASX:CSL) share price are worth watching
The Resmed CDI (ASX:RMD) share price is down around 4.1% since the start of the 2024. It’s probably worth asking, ‘is the RMD share price top value?’
7-Up for S&P/ASX 200 (INDEXASX:XJO)
The benchmark S&P/ASX 200 (INDEXASX: XJO) index added 21.8 points, or 0.3 per cent, to 7600.2 at the closing bell, with seven out of the 11 sectors finishing in the green. The All Ordinaries (INDEXASX: XAO) edged up 0.3 per cent.
S&P/ASX 200 (INDEXASX:XJO) higher ahead of reporting season
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.30% to 7,578.40.